APTO logo

Aptose Biosciences (APTO) Working Capital

Annual Working Capital

-$3.38 M
-$40.61 M-109.06%

31 December 2023

APTO Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$477.00 K
+$3.03 M+118.69%

30 September 2024

APTO Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

APTO Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-109.1%-93.5%
3 y3 years-102.8%-99.5%
5 y5 years-124.6%-98.2%

APTO Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-102.8%at low-99.5%+114.1%
5 y5 years-102.8%at low-99.6%+114.1%
alltimeall time-102.8%+60.0%-99.6%+105.7%

Aptose Biosciences Working Capital History

DateAnnualQuarterly
Sept 2024
-
$477.00 K(-118.7%)
June 2024
-
-$2.55 M(+702.5%)
Mar 2024
-
-$318.00 K(-90.6%)
Dec 2023
-$3.38 M(-109.1%)
-$3.38 M(-146.3%)
Sept 2023
-
$7.29 M(-45.1%)
June 2023
-
$13.29 M(-47.9%)
Mar 2023
-
$25.51 M(-31.5%)
Dec 2022
$37.23 M(-49.4%)
$37.23 M(-19.7%)
Sept 2022
-
$46.34 M(-15.6%)
June 2022
-
$54.88 M(-15.0%)
Mar 2022
-
$64.56 M(-12.2%)
Dec 2021
$73.56 M(-37.8%)
$73.56 M(-16.4%)
Sept 2021
-
$87.97 M(-9.9%)
June 2021
-
$97.60 M(-10.3%)
Mar 2021
-
$108.78 M(-8.0%)
Dec 2020
$118.26 M(+26.9%)
$118.26 M(-8.0%)
Sept 2020
-
$128.50 M(+63.6%)
June 2020
-
$78.54 M(-9.3%)
Mar 2020
-
$86.56 M(-7.2%)
Dec 2019
$93.23 M(+580.6%)
$93.23 M(+249.2%)
Sept 2019
-
$26.70 M(-19.2%)
June 2019
-
$33.05 M(+125.0%)
Mar 2019
-
$14.69 M(+7.2%)
Dec 2018
$13.70 M(+36.2%)
$13.70 M(+0.0%)
Sept 2018
-
$13.70 M(-17.8%)
June 2018
-
$16.66 M(+16.3%)
Mar 2018
-
$14.32 M(+42.3%)
Dec 2017
$10.06 M(+41.4%)
$10.06 M(+3.4%)
Sept 2017
-
$9.73 M(-3.9%)
June 2017
-
$10.12 M(+33.9%)
Mar 2017
-
$7.56 M(+6.3%)
Dec 2016
$7.12 M(-46.7%)
$7.12 M(+7.2%)
Sept 2016
-
$6.64 M(-24.4%)
June 2016
-
$8.78 M(-18.3%)
Mar 2016
-
$10.75 M(-19.4%)
Dec 2015
$13.34 M(-46.7%)
$13.34 M(-19.5%)
Sept 2015
-
$16.56 M(-16.2%)
June 2015
-
$19.76 M(-7.4%)
Mar 2015
-
$21.35 M(-25.0%)
Dec 2014
$25.04 M(-6.1%)
-
Sept 2014
-
$28.48 M(+6.8%)
May 2014
$26.68 M(-3546.0%)
$26.68 M(+531.6%)
Feb 2014
-
$4.22 M(-575.6%)
Nov 2013
-
-$888.20 K(-45.9%)
Aug 2013
-
-$1.64 M(+112.2%)
May 2013
-$774.20 K(-61.7%)
-$774.20 K(-311.9%)
Feb 2013
-
$365.30 K(-77.3%)
Nov 2012
-
$1.61 M(-47.9%)
Aug 2012
-
$3.08 M(-252.5%)
May 2012
-$2.02 M(-1510.6%)
-$2.02 M(+76.8%)
Feb 2012
-
-$1.14 M(+714.5%)
Nov 2011
-
-$140.40 K(-114.0%)
Aug 2011
-
$1.00 M(+597.8%)
May 2011
$143.30 K
$143.30 K(-86.1%)
Feb 2011
-
$1.03 M(+62.3%)
DateAnnualQuarterly
Nov 2010
-
$634.60 K(-128.0%)
Aug 2010
-
-$2.26 M(+84.3%)
May 2010
-$1.23 M(-85.4%)
-$1.23 M(-433.3%)
Feb 2010
-
$368.20 K(-75.9%)
Nov 2009
-
$1.53 M(+134.2%)
Aug 2009
-
$651.90 K(-107.7%)
May 2009
-$8.43 M(-204.2%)
-$8.43 M(+41.5%)
Feb 2009
-
-$5.96 M(+40.7%)
Nov 2008
-
-$4.23 M(-146.1%)
Aug 2008
-
$9.19 M(+13.6%)
May 2008
$8.09 M(+38.9%)
$8.09 M(-27.6%)
Feb 2008
-
$11.17 M(-19.8%)
Nov 2007
-
$13.93 M(-7.4%)
Aug 2007
-
$15.05 M(+158.4%)
May 2007
$5.82 M(+10.2%)
$5.82 M(-3.7%)
Feb 2007
-
$6.05 M(-14.1%)
Nov 2006
-
$7.05 M(-50.8%)
Aug 2006
-
$14.31 M(+170.8%)
May 2006
$5.29 M(-64.1%)
$5.29 M(-18.9%)
Feb 2006
-
$6.52 M(-1848.2%)
Nov 2005
-
-$372.90 K(-103.2%)
Aug 2005
-
$11.71 M(-20.6%)
May 2005
$14.74 M(-11.1%)
$14.74 M(+7.7%)
Feb 2005
-
$13.69 M(+0.4%)
Nov 2004
-
$13.64 M(+5.6%)
Aug 2004
-
$12.92 M(-22.1%)
May 2004
$16.59 M(+9.1%)
$16.59 M(-25.8%)
Feb 2004
-
$22.35 M(-22.6%)
Nov 2003
-
$28.88 M(-7.1%)
Aug 2003
-
$31.09 M(+104.5%)
May 2003
$15.20 M(-34.7%)
$15.20 M(-7.3%)
Feb 2003
-
$16.39 M(-7.6%)
Nov 2002
-
$17.75 M(-12.9%)
Aug 2002
-
$20.37 M(-12.5%)
May 2002
$23.29 M(-19.5%)
$23.29 M(-3.3%)
Feb 2002
-
$24.08 M(-5.7%)
Nov 2001
-
$25.54 M(-6.3%)
Aug 2001
-
$27.26 M(-5.7%)
May 2001
$28.91 M(-19.9%)
$28.91 M(-9.7%)
Feb 2001
-
$32.02 M(-1.6%)
Nov 2000
-
$32.55 M(-8.9%)
Aug 2000
-
$35.71 M(-1.0%)
May 2000
$36.09 M(>+9900.0%)
$36.09 M(+315.6%)
Feb 2000
-
$8.68 M(+93.7%)
Nov 1999
-
$4.48 M(-1056.9%)
Aug 1999
-
-$468.40 K(-445.4%)
May 1999
$135.60 K(-94.7%)
$135.60 K(-88.6%)
Feb 1999
-
$1.19 M(+30.9%)
Nov 1998
-
$911.50 K(-37.4%)
Aug 1998
-
$1.46 M(-42.7%)
May 1998
$2.54 M(-60.7%)
$2.54 M(-26.2%)
Feb 1998
-
$3.44 M(-22.2%)
Nov 1997
-
$4.43 M(-22.2%)
Aug 1997
-
$5.69 M
May 1997
$6.46 M
-

FAQ

  • What is Aptose Biosciences annual working capital?
  • What is the all time high annual working capital for Aptose Biosciences?
  • What is Aptose Biosciences annual working capital year-on-year change?
  • What is Aptose Biosciences quarterly working capital?
  • What is the all time high quarterly working capital for Aptose Biosciences?
  • What is Aptose Biosciences quarterly working capital year-on-year change?

What is Aptose Biosciences annual working capital?

The current annual working capital of APTO is -$3.38 M

What is the all time high annual working capital for Aptose Biosciences?

Aptose Biosciences all-time high annual working capital is $118.26 M

What is Aptose Biosciences annual working capital year-on-year change?

Over the past year, APTO annual working capital has changed by -$40.61 M (-109.06%)

What is Aptose Biosciences quarterly working capital?

The current quarterly working capital of APTO is $477.00 K

What is the all time high quarterly working capital for Aptose Biosciences?

Aptose Biosciences all-time high quarterly working capital is $128.50 M

What is Aptose Biosciences quarterly working capital year-on-year change?

Over the past year, APTO quarterly working capital has changed by -$6.81 M (-93.46%)